pros and cons of glp-1 agonist Frontiers Benefits and Risks of GLP-1
Description
Use of Mounjaro should only be under the supervision of a licensed physician
Back Eckert, N (1 Dec 2023) 'What Is the dark side of GLP-1 receptor agonists?' Medscape Medical News
Updated timeline: May 2026: TRIUMPH-1 Phase 3 topline results announced Late 20262027: Remaining TRIUMPH trials complete
and smaller portion sizes as GLP-1 users dietary preferences transition to calorie-controlled meals and snacks
Neurobiol Aging (2018) 62:3444
